Literature DB >> 26182143

Hepatic arterial infusion combined with systemic chemotherapy induced complete response of metachronous liver metastases after resection of pancreatic insulinoma.

Yuki Kiyozumi1, Hiroshi Takamori2, Osamu Nakahara2, Yoshiaki Ikuta2, Akira Chikamoto2, Toru Beppu2, Hideo Baba2.   

Abstract

Insulinomas are the most common functioning pancreatic neuroendocrine tumors (PNETs). We herein present the case of a 5-year survivor with insulinoma after complete response of postoperative liver metastases to hepatic arterial infusion combined with systemic chemotherapy. A 58-year-old woman was admitted to our hospital following loss of consciousness. Examination revealed a pancreatic tumor, and she underwent distal pancreatectomy following diagnosis of insulinoma. Superparamagnetic iron oxide magnetic resonance imaging (SPIO-MRI) revealed multiple liver metastases 3 months after surgery. Therefore, we performed hepatic arterial infusion of 5-fluorouracil (5-FU) combined with systemic gemcitabine infusion. We observed complete ablation of all metastatic liver nodules after 11 cycles of the chemotherapy using MRI. We continued this chemotherapy regimen for 20 cycles, and the patient remains alive without any recurrence 7 years after surgery.

Entities:  

Keywords:  Chemotherapy; Hepatic arterial infusion; Pancreatic insulinoma

Year:  2013        PMID: 26182143     DOI: 10.1007/s12328-013-0437-3

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  7 in total

1.  Well-differentiated pancreatic tumor/carcinoma: insulinoma.

Authors:  Wouter W de Herder; Bruno Niederle; Jean-Yves Scoazec; Stanislas Pauwels; Gunter Kloppel; Massimo Falconi; Dik J Kwekkeboom; Kjel Oberg; Barbro Eriksson; Bertram Wiedenmann; Guido Rindi; Dermot O'Toole; Diego Ferone
Journal:  Neuroendocrinology       Date:  2007-02-20       Impact factor: 4.914

Review 2.  Pancreatic insulinoma: current issues and trends.

Authors:  Dennis Vaidakis; John Karoubalis; Theodora Pappa; George Piaditis; George N Zografos
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2010-06

Review 3.  New therapeutic options for metastatic malignant insulinomas.

Authors:  Wouter W de Herder; Ellen van Schaik; Dik Kwekkeboom; Richard A Feelders
Journal:  Clin Endocrinol (Oxf)       Date:  2011-09       Impact factor: 3.478

Review 4.  Giant insulinoma: a report of 3 cases and review of the literature.

Authors:  David Callacondo; Jose L Arenas; Armando J Ganoza; Jose Rojas-Camayo; Jose Quesada-Olarte; Hernan Robledo
Journal:  Pancreas       Date:  2013-11       Impact factor: 3.327

5.  5-fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer.

Authors:  Hiroshi Takamori; Keiichiro Kanemitsu; Tatsuya Tsuji; Hiroshi Tanaka; Akira Chikamoto; Osamu Nakahara; Takehisa Hiraoka; Osamu Ikeda; Koichi Kudo; Masanori Imuta; Yasuyuki Yamashita
Journal:  Pancreas       Date:  2005-04       Impact factor: 3.327

6.  Giant pancreatic insulinoma. The bigger the worse? Report of two cases and literature review.

Authors:  Benedetto Ielpo; Riccardo Caruso; Valentina Ferri; Yolanda Quijano; Hipolito Duran; Eduardo Diaz; Isabel Fabra; Ramon Puga; Catalina Oliva; Sergio Olivares; Emilio Vicente
Journal:  Int J Surg Case Rep       Date:  2012-12-11

7.  Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery.

Authors:  D N Danforth; P Gorden; M F Brennan
Journal:  Surgery       Date:  1984-12       Impact factor: 3.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.